Global Patch Pump Drug Delivery Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Patch Pump Drug Delivery Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Patch pumps are the convergence of several technologies into a single drug delivery device package. In doing so, this class of devices overcomes a number of shortcomings and limitations, while simplifying the drug administration event at the patient interface. Patch Pump Drug Delivery System does not have tubing, it is worn like a patch. Insulin pumps, such as Tandem slim X2TM and Animas® (Johnson & Johnson) insulin pump do not classify as patch pumps. Patch pumps have been around for years delivering insulin to diabetes patients with the promise of improving quality of life in managing their disease, but a number of devices have been designed and are being developed to be - within the limits of drug pharmacology - essentially API agnostic. There are however other drugs with treatment regimes that could benefit from the ease of use of a body-worn patch pump and it looks like that is starting to happen.

Market Overview:

The latest research study on the global Patch Pump Drug Delivery market finds that the global Patch Pump Drug Delivery market reached a value of USD 116432.06 million in 2022. It’s expected that the market will achieve USD 171269.13 million by 2028, exhibiting a CAGR of 6.64% during the forecast period.

The growth of the patch pump drug delivery system market is largely driven by downstream

consumptions. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. With incidence rates climbing, medical device manufacturers are seeking solutions to help diabetes patients live active lives, especially for the millions of young people affected by the disease. Key advantage of drug delivery systems is that they allow the drug to target a specific site of action. This enables the drug's effect to be more localized and for sites to be targeted that would otherwise be difficult to reach. Drugs that are more site-specific can also help minimize undesired side effects. What is more, the technological advance, the entrance of international large enterprises, the growth of small businesses will also promote the patch pump drug delivery system market. However, side effects, the promulgation of relevant laws and regulations, especially in North America and Europe will affect the development of the industry to a certain extent. Alternatives are easy to get, such as pens, syringes, and injectors, they are much cheaper, user-friendly and reliable in our daily life. Other limitations include the device complexity, reimbursement constraints and high out-of-pocket-cost for patients.

Driving Factors

Improving living standards all over the world Growing population of diabetics world wide Smaller, more discrete and easier to use Patch Pump Drug Delivery System.

Market Restraints

Technology Concentrated Long product development cycle Each country's regulatory measures are more stringent Strict regulations from FDA and European countries.

Opportunities

Government Policy Support Human-friendly product development.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

The top three companies are Insulet Corporation, Medtronic, Valeritas, with the revenue market share of 39.76%, 14.58%, and 8.75% in 2016.

Segmentation Overview:

Among different product types, Electronic Delivery Devices segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the Type 1 Diabetes segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Patch Pump Drug Delivery market covered in Chapter 3:

Cellnovo Limited.
Debiotech S.A.
Amgen
Sensile Medical AG
ToucheMedical
Insulet Corporation
Medtronic
CeQur SA.
Weibel CDS AG
EOFLOW CO., LTD.
Valeritas

In Chapter 4 and Chapter 14.2, on the basis of types, the Patch Pump Drug Delivery market from 2018 to 2029 is primarily split into:

Mechanical Delivery Devices
Electronic Delivery Devices

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Patch Pump Drug Delivery market from 2018 to 2029 covers:

Type 1 Diabetes
Type 2 Diabetes
others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)